Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Disintegrin and metalloproteinase domain-containing protein 17 | ||
Ligand | BDBM50100 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Counterscreen for exosite inhibitors of ADAM10: QFRET-based biochemical high throughput dose response assay to identify inhibitors of ADAM17 | ||
IC50 | 33734±n/a nM | ||
Citation | PubChem, PC Counterscreen for exosite inhibitors of ADAM10: QFRET-based biochemical high throughput dose response assay to identify inhibitors of ADAM17 PubChem Bioassay(2014)[AID] | ||
More Info.: | Get all data from this article, Solution Info, Assay Method | ||
Disintegrin and metalloproteinase domain-containing protein 17 | |||
Name: | Disintegrin and metalloproteinase domain-containing protein 17 | ||
Synonyms: | ADA17_HUMAN | ADAM17 | CSVP | Disintegrin and metalloproteinase domain-containing protein 17 (ADAM-17) | Disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) | TACE | TNF-alpha convertase | TNF-alpha converting enzyme (TACE) | TNF-alpha-converting enzyme (TACE) | Tumor Necrosis Factor Alpha Converting Enzyme | Tumor necrosis factor-α converting enzyme (TACE) | ||
Type: | Enzyme | ||
Mol. Mass.: | 93007.89 | ||
Organism: | Homo sapiens (Human) | ||
Description: | |||
Residue: | 824 | ||
Sequence: |
| ||
BDBM50100 | |||
n/a | |||
Name | BDBM50100 | ||
Synonyms: | (5E)-5-[[4-(4-methylphenyl)-2-thiophen-2-yl-4H-1-benzopyran-3-yl]methylidene]-2-sulfanylidene-4-thiazolidinone | (5E)-5-[[4-(4-methylphenyl)-2-thiophen-2-yl-4H-chromen-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | (5E)-5-[[4-(p-tolyl)-2-(2-thienyl)-4H-chromen-3-yl]methylene]-2-thioxo-thiazolidin-4-one | 5-[1-(2-Thiophen-2-yl-4-p-tolyl-4H-chromen-3-yl)-meth-(E)-ylidene]-2-thioxo-thiazolidin-4-one | MLS000595348 | SMR000149871 | cid_9551861 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H17NO2S3 | ||
Mol. Mass. | 447.592 | ||
SMILES | Cc1ccc(cc1)C1C(C=C2SC(S)=NC2=O)=C(Oc2ccccc12)c1cccs1 |w:9.9,c:14,18,(11.05,-6.19,;11.05,-4.65,;9.72,-3.88,;9.72,-2.34,;11.05,-1.57,;12.38,-2.34,;12.38,-3.88,;11.05,-.03,;9.72,.74,;8.38,-.03,;7.05,.74,;5.64,.11,;4.61,1.26,;3.08,1.1,;5.38,2.59,;6.89,2.27,;8.03,3.3,;9.72,2.28,;11.05,3.05,;12.38,2.28,;13.76,3.1,;15.16,2.31,;15.16,.71,;13.76,-.08,;12.38,.74,;9.72,3.82,;10.96,4.73,;10.49,6.19,;8.95,6.19,;8.47,4.73,)| | ||
Structure |